ArticleHemaSphere2025

Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition.

Anna Ossami Saidy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.